ReviewClinical and experimental medicine2026
Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases.
Review in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Macrophages are key regulators of cutaneous immunity, but the traditional M1/M2 polarization model cannot fully explain their functional diversity across skin diseases. In this narrative review, we use selected skin diseases to discuss a receptor-centered view of macrophage function and to illustrate a modular "receptor-pathway-effector" framework. This perspective places macrophage receptors at the upstream sensing level, where microbial products, tissue damage signals, cytokines, immune complexes, stromal cues, and tumor-derived signals are translated into inflammatory, reparative, fibrotic, or immunosuppressive programs. We summarize representative receptor modules, including pattern-recognition receptors, cytokine and chemokine receptors, Fc and complement receptors, scavenger and efferocytosis receptors, and inhibitory checkpoint receptors. Across psoriasis, atopic dermatitis, autoimmune blistering diseases, lupus, systemic sclerosis, sarcoidosis, leprosy, melanoma, cutaneous T-cell lymphoma, diabetic wounds, and radiation-induced skin injury, these modules help explain macrophage involvement in inflammation, remodeling, host defense, impaired repair, and tumor immune escape. We also discuss selected biomarker and therapeutic examples, while distinguishing clinically explored approaches from preclinical or emerging concepts. This receptor-centered perspective may complement existing views of macrophage heterogeneity and provide a clearer way to link receptor signals with disease-related macrophage functions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.